Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (301-310 of 991) with videos related to

Pageof 100
Sort By:
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Case study: the link between hypertension and diabetesGeorge L Bakris, Edgar R Gonzalez
Current Opinion in Nephrology and Hypertension|June 19, 2004
The role of calcium antagonists in chronic kidney diseaseCasey N Gashti, George L Bakris
Advances in Chronic Kidney Disease|December 19, 2021
Mineralocorticoid Receptor Antagonists-Evidence for Kidney Protection, Trials With Novel AgentsOmar Al Dhaybi, George L Bakris
Expert Opinion on Investigational Drugs|October 1, 2021
An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertensionBertram Pitt, Frederic Jaisser, George Bakris
Journal of the American College of Cardiology|June 15, 2019
ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline ComparisonGeorge Bakris, Waleed Ali, Gianfranco Parati
Diabetes, Obesity & Metabolism|March 18, 2022
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetesRalph A DeFronzo, George L Bakris
Diabetic Medicine : a Journal of the British Diabetic Association|May 24, 2018
Hyperkalaemia in diabetes: a silent risk predicting poor outcomesF K Dojki, G L Bakris
Disease-A-Month : DM|August 1, 1993
Diabetic nephropathyG L Bakris, J H Stein
Journal of Human Hypertension|January 1, 1997
The Lanai Symposium: hypertensive patient profiles: approaches to management and disease preventionG L Bakris, F H Messerli
Journal of the American Society of Hypertension : JASH|April 23, 2010
Treatment of hypertension in patients with diabetes-an updateGeorge L Bakris, James R Sowers,
Pageof 100

Showing results (301-310 of 991) with videos related to

Sort By:
Pageof 100
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Case study: the link between hypertension and diabetesGeorge L Bakris, Edgar R Gonzalez
Current Opinion in Nephrology and Hypertension|June 19, 2004
The role of calcium antagonists in chronic kidney diseaseCasey N Gashti, George L Bakris
Advances in Chronic Kidney Disease|December 19, 2021
Mineralocorticoid Receptor Antagonists-Evidence for Kidney Protection, Trials With Novel AgentsOmar Al Dhaybi, George L Bakris
Expert Opinion on Investigational Drugs|October 1, 2021
An evaluation of KBP-5074 in advanced chronic kidney disease with uncontrolled hypertensionBertram Pitt, Frederic Jaisser, George Bakris
Journal of the American College of Cardiology|June 15, 2019
ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline ComparisonGeorge Bakris, Waleed Ali, Gianfranco Parati
Diabetes, Obesity & Metabolism|March 18, 2022
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetesRalph A DeFronzo, George L Bakris
Diabetic Medicine : a Journal of the British Diabetic Association|May 24, 2018
Hyperkalaemia in diabetes: a silent risk predicting poor outcomesF K Dojki, G L Bakris
Disease-A-Month : DM|August 1, 1993
Diabetic nephropathyG L Bakris, J H Stein
Journal of Human Hypertension|January 1, 1997
The Lanai Symposium: hypertensive patient profiles: approaches to management and disease preventionG L Bakris, F H Messerli
Journal of the American Society of Hypertension : JASH|April 23, 2010
Treatment of hypertension in patients with diabetes-an updateGeorge L Bakris, James R Sowers,
Pageof 100